Nike names David M. Denton as new CFO ahead of Q4 earnings
Nike Inc. named David M. Denton as its new Executive Vice President and CFO, effective August 17, replacing Matthew Friend. The company is preparing for its fiscal fourth-quarter earnings report, with analysts projecting earnings per share of 12 cents and revenue of $10.85 billion. Recent analyst actions include a downgrade to Sector Weight by Keybanc and a price target cut by BTIG, while the stock holds a Hold rating with an average target of $52.94.

*this image is generated using AI for illustrative purposes only.
Nike Inc. shares are in focus as the company announced a leadership transition and prepares for its fiscal fourth-quarter earnings report next week. The sportswear giant named David M. Denton as Executive Vice President and CFO, effective August 17, succeeding Matthew Friend. This change comes as the stock tests key support levels and analysts adjust their ratings ahead of the financial disclosure.
CFO Transition
Denton joins Nike from Pfizer, where he has served as CFO since May 2022. He brings over 30 years of finance and operating leadership experience, including previous CFO roles at Lowe’s and CVS Health. Matthew Friend will step down on August 17 and remain with the company through September 4 to support the transition. Friend is scheduled to participate in Nike’s fourth quarter fiscal 2026 earnings call on June 30 as planned. CEO Elliott Hill praised Denton as a proven public-company CFO capable of helping consumer brands operate with discipline.
Analyst Consensus & Recent Actions
The stock currently holds a Hold rating with an average price target of $52.94. Recent analyst activity reflects mixed sentiment:
| Firm | Rating | Price Target | Action Date |
|---|---|---|---|
| Keybanc | Sector Weight | N/A | June 26 |
| BTIG | Buy | $55.00 | June 25 |
| BNP Paribas | Underperform | $23.00 | June 23 |
Earnings & Key Metrics
Nike is expected to report earnings per share of 12 cents and revenue of $10.85 billion for the upcoming quarter. In the prior quarter, the company reported earnings per share of 35 cents, beating the consensus estimate of 28 cents, and revenue of $11.28 billion, which exceeded the consensus estimate of $11.23 billion.
Investors are advised to monitor same-store sales growth and e-commerce trends, which are critical for Nike’s recovery strategy. Inventory levels will also be under scrutiny, as significant increases could signal overproduction and further margin strain amidst current demand challenges.
Market Reaction
At the time of publication, Nike shares were trading 0.76% lower at $40.59.
How will David Denton's background in the pharmaceutical sector influence Nike's financial strategy compared to his predecessor?
What specific operational changes might the new CFO implement to address the anticipated margin strain and inventory challenges?
Could the mixed analyst ratings and the wide disparity in price targets indicate a deeper uncertainty about Nike's near-term recovery trajectory?

































